secwatch.observer — SEC 8-K summary
======================================

Issuer:     Telomir Pharmaceuticals, Inc. (TELO)
CIK:        0001971532
Form:       8-K
Filed at:   2024-06-24T23:59:59+00:00
Accession:  0001493152-24-024812
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Telomir Pharma CFO Nathan Fuentes resigns; Michelle Yanez appointed CFO
-----------------------------------------------------------------------

- CFO Nathan Fuentes resigned June 18, 2024; separation includes $62,500 over 3 months and option extension.
- Michelle Yanez, MBA, appointed CFO effective June 18; was part-time Corporate Controller since May 2022.
- Yanez also serves as CFO of MIRA Pharmaceuticals (Nasdaq: MIRA); base salary $137,500/yr.
- Yanez receives sign-on bonus tied to change of control, discretionary annual bonus, no upfront equity.
- Resignation was not based on any disagreement with Company's operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1971532/000149315224024812/0001493152-24-024812-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1971532/000149315224024812/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-024812

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer